These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10439166)

  • 1. The role of positron emission tomography in occult primary head and neck cancers.
    Safa AA; Tran LM; Rege S; Brown CV; Mandelkern MA; Wang MB; Sadeghi A; Juillard G
    Cancer J Sci Am; 1999; 5(4):214-8. PubMed ID: 10439166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
    Yao M; Graham MM; Hoffman HT; Smith RB; Funk GF; Graham SM; Dornfeld KJ; Skwarchuk M; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1001-10. PubMed ID: 15234033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
    Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
    Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
    Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
    Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
    Stokkel MP; ten Broek FW; van Rijk PP
    Eur J Nucl Med; 1999 May; 26(5):499-503. PubMed ID: 10382094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
    Rogers JW; Greven KM; McGuirt WF; Keyes JW; Williams DW; Watson NE; Geisinger K; Cappellari JO
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):694-7. PubMed ID: 14967422
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S
    Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
    Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
    Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
    AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
    Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
    Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
    Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
    Stokkel MP; ten Broek FW; Hordijk GJ; Koole R; van Rijk PP
    Ann Surg; 2000 Feb; 231(2):229-34. PubMed ID: 10674615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of FDG PET on the management of occult primary head and neck tumours.
    Wong WL; Saunders M
    Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):461-6. PubMed ID: 14690001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
    Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
    Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
    Kitagawa Y; Sadato N; Azuma H; Ogasawara T; Yoshida M; Ishii Y; Yonekura Y
    J Nucl Med; 1999 Jul; 40(7):1132-7. PubMed ID: 10405132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
    Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
    Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
    Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.